CARs: a new approach for the treatment of autoimmune diseases

The development of chimeric antigen receptor (CAR)-based therapeutic interventions represented a breakthrough in cancer treatment. Following the success of the CAR-T-cell strategy, this novel therapeutic approach has been applied to other diseases, including autoimmune diseases. Using CAR-T cells to...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Yeting, Yuan, Yeshuang, Zhang, Bo, Zhang, Xuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Science China Press 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9641699/
https://www.ncbi.nlm.nih.gov/pubmed/36346550
http://dx.doi.org/10.1007/s11427-022-2212-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9641699/
https://www.ncbi.nlm.nih.gov/pubmed/36346550
http://dx.doi.org/10.1007/s11427-022-2212-5

Ejemplares similares